1. Home
  2. PCVX vs APPF Comparison

PCVX vs APPF Comparison

Compare PCVX & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • APPF
  • Stock Information
  • Founded
  • PCVX 2013
  • APPF 2006
  • Country
  • PCVX United States
  • APPF United States
  • Employees
  • PCVX N/A
  • APPF N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • APPF Computer Software: Prepackaged Software
  • Sector
  • PCVX Health Care
  • APPF Technology
  • Exchange
  • PCVX Nasdaq
  • APPF Nasdaq
  • Market Cap
  • PCVX 4.5B
  • APPF 7.9B
  • IPO Year
  • PCVX 2020
  • APPF 2015
  • Fundamental
  • Price
  • PCVX $31.16
  • APPF $214.29
  • Analyst Decision
  • PCVX Strong Buy
  • APPF Buy
  • Analyst Count
  • PCVX 10
  • APPF 6
  • Target Price
  • PCVX $136.50
  • APPF $271.20
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • APPF 349.3K
  • Earning Date
  • PCVX 05-07-2025
  • APPF 04-24-2025
  • Dividend Yield
  • PCVX N/A
  • APPF N/A
  • EPS Growth
  • PCVX N/A
  • APPF 158.56
  • EPS
  • PCVX N/A
  • APPF 5.36
  • Revenue
  • PCVX N/A
  • APPF $824,474,000.00
  • Revenue This Year
  • PCVX N/A
  • APPF $20.11
  • Revenue Next Year
  • PCVX N/A
  • APPF $16.68
  • P/E Ratio
  • PCVX N/A
  • APPF $40.25
  • Revenue Growth
  • PCVX N/A
  • APPF 22.73
  • 52 Week Low
  • PCVX $27.66
  • APPF $189.01
  • 52 Week High
  • PCVX $121.06
  • APPF $274.56
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • APPF 49.40
  • Support Level
  • PCVX $28.09
  • APPF $198.70
  • Resistance Level
  • PCVX $33.75
  • APPF $217.75
  • Average True Range (ATR)
  • PCVX 2.54
  • APPF 7.40
  • MACD
  • PCVX 1.12
  • APPF 0.58
  • Stochastic Oscillator
  • PCVX 35.61
  • APPF 53.73

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: